PRILIGY

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug PRILIGY contains one active pharmaceutical ingredient (API):

1 Dapoxetine UNII U4OHT63MRI - DAPOXETINE HYDROCHLORIDE

Dapoxetine is a potent selective serotonin reuptake inhibitor (SSRI). The mechanism of action of dapoxetine in premature ejaculation is presumed to be linked to the inhibition of neuronal reuptake of serotonin and the subsequent potentiation of the neurotransmitter’s action at pre- and postsynaptic receptors. Read about Dapoxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRILIGY Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BX14	Dapoxetine	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BX Other urologicals
Discover more medicines within G04BX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4355-MEE-0818, 4433-MEE-1018
Country: EE	Ravimiamet	Identifier(s): 1488955, 1488966, 1488977, 1488988, 1489002, 1489013, 1489024, 1489035
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70874, 70875
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 188811, 441646
Country: FR	Base de données publique des médicaments	Identifier(s): 67084087, 67428136
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 233617, 233618, 233622, 233623
Country: HK	Department of Health Drug Office	Identifier(s): 60174, 60175
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-635589393, HR-H-674827417
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1055892, 1055893, 1066116, 1066117, 1066118, 1066119, 1066120, 1066121
Country: MT	Medicines Authority	Identifier(s): MA1022/00101, MA1022/00102
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 132M2009
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106437, 106445
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13373, 13376
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100282745, 100282751
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W59982001, W59982002, W59982003, W59982004, W59983001, W59983002, W59983003, W59983004
Country: SG	Health Sciences Authority	Identifier(s): 13880P, 13881P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699832090536, 8699832090543, 8699832090550, 8699832090567, 8699832090574, 8699832090581
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/18.10/0692, 43/18.10/0693